Haemonetics is trading 4.3% up at $107.06, outperforming a broadly weaker market on September 14, 2026, in a primarily sector-driven move as investors seek defensive exposure.
- Healthcare is up 1.28% amid oil-price, interest-rate, and technology-sector concerns.
- No clear company-specific announcement, earnings release, or analyst action was identified.
- A Baird Global Healthcare Conference presentation is scheduled for September 15, but no evidence links it directly to today’s gain.